世界の一次細胞市場 – 業界動向と2029年までの予測

 一次細胞市場の分析と規模

主な細胞培養市場は、高齢者人口の増加、慢性疾患の増加、研究開発の進歩により成長を遂げています。世界中の医薬品市場は、高度な医薬品の開発と試験に多額の投資を集めています。

Data Bridge Market Research の分析によると、2021 年に 12 億 4,000 万米ドルだった一次細胞市場は、2022 年から 2029 年の予測期間中に 11.30% の CAGR で成長し、2029 年には 29 億 2,000 万米ドルに達すると予想されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Research がまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

一次細胞市場の範囲とセグメンテーション      

市場の定義

Primary cells refer to cells taken directly from living tissues of animals or humans and are then processed to establish them for use in appropriate cell therapies. Primary cells are widely used in various applications, including 3D cell culture, virology, cancer research, stem cell therapy, and tissue replacement. Researchers are increasingly using the 3D cell culture product to study cell biology and biochemistry, drug effects, cell signaling, and cell-pathogen interactions. The pharmaceutical industry uses the product to investigate drug cytotoxicity, produce biomolecules, and develop vaccines. The use of primary cells eliminates the need for animal models in vaccine development. Viruses can be detected and isolated to determine the mode of infection using primary cells.

Global Primary Cells Market Dynamics

Drivers

• Robust Investments into Research and Development (R&D)

Significant investments in R&D activities are rapidly driving the global market for primary cells to develop effective therapies in which primary cells can be used to treat various immunodeficiency disorders. Because of the growth of the biotechnology and biopharmaceutical industries, medical researchers are constantly working on using primary cells from animal or human tissue to treat malignant cancers. Furthermore, the use of patient-derived specimens in innovative preclinical technologies, such as 3D cell cultures, is driving the growth of the primary cell market. Furthermore, the use of human primary cells is increasingly becoming a preferred choice for studying the effects of cancer cells on the human body without using animal cells.

• Rising Cases of Cancers

The consistent growth in the global market for primary cells can be linked to the increasing occurrence of cancers around the world. Primary cells are used for cancer cell discovery and drug screening due to their superiority over cell lines, which is fuelling market growth. Furthermore, primary cells are used in extensive research activities to develop relevant therapies and techniques, such as cell therapies and regenerative therapies, to treat cancer patients; because cancer is recognized as the leading cause of death worldwide, governments and private institutes all over the world are rapidly investing in advanced healthcare technologies for effective cancer treatment, providing impetus to the primary cell market growth.

Opportunities

• Drug Screening and Toxicity Testing

To investigate the cytotoxicity of new drugs, primary cell cultures are used. It is useful for industrial-scale synthesis or production of a wide range of biomolecules. This is especially helpful in the pharmaceutical industry. Several research projects on cell-based therapeutic products based on primary cells are currently being developed. Primary culture is used instead of animal models to test the effects of new drugs, cosmetics, and chemicals. They are also used to calculate the maximum allowable dosage of new drugs. These are some of the factors expected to propel the market's growth.

Restraints/Challenges

• Concerns Regarding Primary Cell Culture Contamination

Cell contamination is one of the major problems in cell culture laboratories. Using contaminated cells endangers physiology, leads to incorrect results, and causes loss of unique cell lines.

This primary cells market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the primary cells market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Primary Cells Market

According to the WHO, 70 vaccine under development and 3 are already in human trials. The pandemic's economic and social burden has prompted global government bodies to increase support for vaccine development, which has led to increased adoption rates of primary cells for COVID-19 research.

Recent developments

• In March 2021, Axol Bioscience Ltd., a global leader in the market for primary cells, recently announced a merger with Censo Biotechnologies. The merged company is focused on providing product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets.

Global Primary Cells Market Scope

The primary cells market is segmented on the basis of type, origin, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Animal Primary Cells
• Human Primary Cells
• Others

Origin

• Dermatocytes
• Gastrointestinal Cells
• Heart Cells
• Hematopoietic Cells
• Hepatocytes
• Cryopreserved hepatocytes
•  Fresh hepatocytes
• Lung Cells
• Musculoskeletal Cells
• Renal Cells
• Others

End User

• Life Science Research Companies
• Research Institutes

Primary Cells Market Regional Analysis/Insights

The primary cells market is analyzed and market size insights and trends are provided by country, type, origin, and end user as referenced above.

The countries covered in the primary cells market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the primary cells market owing to the growing government funding in research, rising prevalence of cancer in the region and technological advancements.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising per capita health spending and rising geriatric population base.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The primary cells market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for primary cells market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the primary cells market. The data is available for historic period 2010-2020.

Competitive Landscape and Primary Cells Market Share Analysis

The primary cells market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to primary cells market.

Some of the major players operating in the primary cells market are:

• Thermo Fisher Scientific Inc (U.S.)
• Merck Group (Germany)
• Lonza (Switzerland)
• Cell Biologics, Inc. (U.S.)
• PromoCell - 人間中心の科学（ドイツ）
• ZenBio, Inc.（米国）
• STEMCELL Technologies Inc (カナダ)
• AllCells（米国）
• ATCC（米国）
• アクソールバイオサイエンス（英国）
• リーチバイオリサーチラボ（米国）
• チャールズリバーラボラトリーズ（米国）
• クリエイティブバイオアレイ（米国）
• PELOBIOTECH GmbH（ドイツ）
• シグマアルドリッチ社（米国）

調査方法: 世界の一次細胞市場

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせ内容をドロップダウンしてください。

DBMR リサーチ チームが使用する主要なリサーチ手法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これ以外にも、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。リサーチ手法について詳しくは、お問い合わせフォームから当社の業界の専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合ったデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、再開発市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社を必要なだけ追加し、必要な形式とデータ スタイルでデータを作成できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクトブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。 

SKU-56543